ZURA

Zura Bio Limited Class A · NASDAQ

Sector Health Technology
Industry Biotechnology
Website zurabio.com
Employees(FY) -
ISIN KYG9TY5A1016

Performance

+3.64%

-27.62%

-46.98%

-32.54%

-51.18%

YTD

-52.8%

Profile

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.

Advanced Technical Analysis

Technical Analysis of ZURA 2024-12-20

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 3 indicating strong downward pressure, while the Oscillators Score of 46 suggests a neutral stance, and the Technical Score of 25 reinforces the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to b...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ZURA

Stock Rank

Recent News & Updates

2024-11-24 17:30
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference(Businesswire)
2024-11-14 03:30
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis(Businesswire)
2024-11-06 17:30
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates(Businesswire)
2024-10-29 18:30
Zura Bio to Participate in Two Upcoming Investor Conferences in November(Businesswire)
2024-09-02 18:00
Zura Bio to Present at Three Upcoming Investor Conferences in September(Businesswire)
2024-08-12 21:21
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights(Businesswire)
2024-08-12 04:05
Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants(Businesswire)
2024-08-09 04:05
Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants(Businesswire)
2024-07-31 20:00
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors(Globenewswire)
2024-07-11 18:10
Zura Bio Commences Warrant Exchange Offer and Consent Solicitation(Businesswire)
2024-07-11 18:08
The 3 Most Undervalued Biotech Stocks to Buy in July 2024(Investorplace)
2024-06-13 18:00
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024(Businesswire)
2024-06-05 18:00
Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology(Businesswire)
2024-06-02 18:00
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024(Businesswire)
2024-05-30 21:55
Wall Street Analysts Predict a 235.2% Upside in Zura Bio Limited (ZURA): Here's What You Should Know(Zacks)
2024-05-28 18:00
Zura Bio Announces Participation in June Investor Conferences(Businesswire)
2024-05-23 18:18
3 Penny Stocks to Buy Now: May 2024(Investorplace)
2024-05-14 21:55
How Much Upside is Left in Zura Bio Limited (ZURA)? Wall Street Analysts Think 248.84%(Zacks)
2024-05-14 00:00
Zura Bio Limited (ZURA) Upgraded to Buy: Here's What You Should Know(Zacks)
2024-05-12 03:26
13 Penny Stocks with Insider Buying in 2024(Insidermonkey)
2024-05-10 03:14
Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments(Yahoo Finance)
2024-05-09 01:56
ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024(Investorplace)
2024-05-08 18:00
Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights(Businesswire)
2024-04-24 14:18
Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA)(Yahoo Finance)
2024-04-17 21:22
Zura Bio Announces Oversubscribed $112.5 Million Private Placement(Businesswire)
2024-04-07 18:00
Zura Bio Announces Robert Lisicki as CEO and Director(Businesswire)
2024-03-27 23:54
ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023(Investorplace)
2024-03-27 18:00
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer(Businesswire)
2024-03-03 17:00
Zura Bio Announces Participation at March Conferences(Businesswire)
2024-02-01 17:00
Zura Bio Announces Participation at February Investor Conferences(Businesswire)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.